Rapport Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rapport therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rapport Therapeutics Today - Breaking & Trending Today

Rapport's Stock Market Debut Reaps $154M as Novel Epilepsy Med Heads for Mid-Stage Test

Rapport's Stock Market Debut Reaps $154M as Novel Epilepsy Med Heads for Mid-Stage Test
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

United States , Goldman Sachs , Rapport Therapeutics , Third Rock Ventures , Johnson Innovation , Venture Partners , Sofinnova Ventures ,

Rapport Therapeutics, Inc. Plans $136 Million IPO for June 7th (RAPP)

Rapport Therapeutics, Inc. (RAPP) expects to raise $136 million in an initial public offering (IPO) on Friday, June 7th, IPO Scoop reports. The company will be issuing 8,000,000 shares at $16.00-$18.00 per share. Rapport Therapeutics, Inc. has a market cap of $601.4 million. Goldman Sachs, Jefferies, TD Cowen and Stifel served as the underwriters for […] ....

United States , San Francisco , David Bredt , Eli Lilly , News Ratings For Rapport Therapeutics Inc , University Of California , Goldman Sachs , Rapport Therapeutics Inc , Rapport Therapeutics , Third Rock Ventures , Chief Scientific Officer , Global Head , Neuroscience Discovery , Janssen Pharmaceutica , Vice President , Janssen License ,

Rapport Therapeutics, Inc. (RAPP) Announces June 7th IPO

Rapport Therapeutics, Inc. (RAPP) expects to raise $136 million in an IPO on Friday, June 7th, IPO Scoop reports. The company will be issuing 8,000,000 shares at a price of $16.00-$18.00 per share. Rapport Therapeutics, Inc. has a market-cap of $601.4 million. Goldman Sachs, Jefferies, TD Cowen and Stifel served as the underwriters for the […] ....

San Francisco , United States , David Bredt , Eli Lilly , Goldman Sachs , News Ratings For Rapport Therapeutics Inc , Rapport Therapeutics Inc , University Of California , Rapport Therapeutics , Third Rock Ventures , Chief Scientific Officer , Global Head , Neuroscience Discovery , Janssen Pharmaceutica , Vice President , Janssen License ,

Rapport Therapeutics, Inc. (RAPP) to Raise $136 Million in IPO

Rapport Therapeutics, Inc. (RAPP) is planning to raise $136 million in an IPO on Friday, June 7th, IPO Scoop reports. The company plans to issue 8,000,000 shares at a price of $16.00-$18.00 per share. The company has a market-cap of $601.4 million. Goldman Sachs, Jefferies, TD Cowen and Stifel served as the underwriters for the […] ....

United States , San Francisco , David Bredt , Eli Lilly , Goldman Sachs , University Of California , News Ratings For Rapport Therapeutics Inc , Rapport Therapeutics Inc , Rapport Therapeutics , Third Rock Ventures , Chief Scientific Officer , Global Head , Neuroscience Discovery , Janssen Pharmaceutica , Vice President , Janssen License ,

Hedge Funds Hope to Cash in on Biopharma IPO

Hedge Funds Hope to Cash in on Biopharma IPO
institutionalinvestor.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from institutionalinvestor.com Daily Mail and Mail on Sunday newspapers.

Raymond Kelleher , Cormorant Private Healthcare Fund , Cormorant Global Healthcare Master Fund , Rapport Therapeutics , Cormorant Asset , Global Healthcare Master Fund , Perceptive Advisors , Surveyor Capital , Third Rock Ventures , Johnson Innovation ,